![Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-81321-5/MediaObjects/41598_2021_81321_Fig1_HTML.png)
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
![PDF] Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. | Semantic Scholar PDF] Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d77f084220c8e624c83be6585a40f1c1b22c58a4/5-Figure3-1.png)
PDF] Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. | Semantic Scholar
![Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ] Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/13385/1/fig-1-full.png)
Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]
![Frontiers | Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients? Frontiers | Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?](https://www.frontiersin.org/files/Articles/1056293/fonc-12-1056293-HTML-r1/image_m/fonc-12-1056293-g001.jpg)
Frontiers | Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?
![PDF) Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio PDF) Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio](https://i1.rgstatic.net/publication/311492262_Serum_Free_Light_Chain_Assay_and_kl_Ratio_Performance_in_Patients_With_Monoclonal_Gammopathy-High_False_Negative_Rate_for_kl_Ratio/links/594ad0510f7e9ba3beafb293/largepreview.png)
PDF) Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio
![Graph of urine protein/creatinine ratio (gram protein/gram creatinine),... | Download Scientific Diagram Graph of urine protein/creatinine ratio (gram protein/gram creatinine),... | Download Scientific Diagram](https://www.researchgate.net/publication/332878282/figure/fig1/AS:755601353232385@1557160809394/Graph-of-urine-protein-creatinine-ratio-gram-protein-gram-creatinine-serum-creatinine.png)
Graph of urine protein/creatinine ratio (gram protein/gram creatinine),... | Download Scientific Diagram
![PDF] Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies | Semantic Scholar PDF] Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6f55a915f00908f1c3a6da9b9cd3dd78737be3ca/3-Figure2-1.png)
PDF] Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies | Semantic Scholar
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
![Structural analysis of urinary light chains and proteomic analysis of hyaline tubular casts in light chain associated kidney disorders [PeerJ] Structural analysis of urinary light chains and proteomic analysis of hyaline tubular casts in light chain associated kidney disorders [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/7819/1/fig-5-2x.jpg)
Structural analysis of urinary light chains and proteomic analysis of hyaline tubular casts in light chain associated kidney disorders [PeerJ]
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
![PDF) Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With PDF) Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With](https://i1.rgstatic.net/publication/325548624_Serum_Free_Light_Chains_in_Neoplastic_Monoclonal_Gammopathies_Relative_Under-Detection_of_Lambda_Dominant_KappaLambda_Ratio_and_Underproduction_of_Free_Lambda_Light_Chains_as_Compared_to_Kappa_Light_C/links/5b15399b4585150a0a674cbd/largepreview.png)
PDF) Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig1_HTML.png)